“Children’s healthcare must always be evidence-led,” he said. The existing treatment and prescription process for gender dysphoria.
And incongruence poses an intolerable safety risk to children and adolescents, according to the independent expert Commission on Human Medicines.
“The paucity of data supporting these medical procedures also sparked safety concerns in Dr. Cass’s evaluation. When it comes to this vulnerable group of youth, we must exercise prudence.
And care and heed the counsel of experts. “We are working with NHS England to open new gender identity services, so people can access holistic health and wellbeing support they need.”
“We are setting up a clinical trial into the use of puberty blockers next year, to establish a clear evidence base for the use of this medicine.”
The head of the Cass Review on gender healthcare for kids, Dr. Hilary Cass, called puberty blockers “powerful drugs with unproven benefits and significant risks.”
